14，Jodo S, Kobayashi S, Kayagaki N, et al. Serum levels of soluble Fas/Apo-1(CD95) andits molecular structure in patients with systemic lupus erythematosus(SLE) and otherautoimmune disease. Clin Exp Immunol, 1997,107(1):89
25，Hasunuma T, Kayagaki N, Asahara H, et al. Accumulation of soluble Fas in inflamedjoints of patients with rheumatoid arthritis. Arthritis Rheumatism, 1997,40(9):80
36，Hiromatsu Y, Bednarczuk T, Soyejima E, et al. Increased serum soluble Fas in patientswith Graves′ disease. Thyroid, 1999,9(4):341
(1999-12-10 收稿)
